1-6 of 6
Vamsi Bollu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Healthcare Resource Utilization and Costs in Patients with Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy with Tisagenlecleucel: Results from the Elara Study

Nathan H. Fowler, Michael Dickinson, Monalisa Ghosh, Andy Chen, Charalambos Andreadis, Ranjan Tiwari, Aisha Masood, Roberto Ramos, Vamsi Bollu, Etienne Jousseaume, Catherine Thieblemont, Martin H. Dreyling, Stephen J. Schuster
Journal: Blood
Blood (2021) 138 (Supplement 1): 3533.
https://doi.org/10.1182/blood-2021-145741
Published: 2021
Journal Articles

A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)

Gilles Salles, Stephen J. Schuster, Luca Fischer, John Kuruvilla, Piers EM Patten, Bastian von Tresckow, Sonali M. Smith, Ana Isabel Jiminez Ubieto, Keith L. Davis, Saurabh P Nagar, Jie Zhang, Vamsi Bollu, Etienne Jousseaume, Roberto Ramos, Yucai Wang, Brian K. Link
Journal: Blood
Blood (2021) 138 (Supplement 1): 1349.
https://doi.org/10.1182/blood-2021-145870
Published: 2021
Journal Articles

Treatment Regimens and Clinical Outcomes Among Follicular Lymphoma Patients Treated with Third-Line Therapy in the United States: A Real-World EHR Study

Dong Dai, Ji Haeng Heo, Andrew Rava, Etienne Jousseaume, Roberto Ramos, Vamsi Bollu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1360.
https://doi.org/10.1182/blood-2021-147638
Published: 2021
Journal Articles

Comparison of Adherence Between Nilotinib and Dasatinib as Second-Line Therapies In Chronic Myeloid Leukemia.

Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Amy Guo, PhD, James D. Griffin, MD, Andrew Peng Yu, PhD, Eric Qiong Wu, PhD
Journal: Blood
Blood (2010) 116 (21): 3437.
https://doi.org/10.1182/blood.V116.21.3437.3437
Published: 2010
Journal Articles

The Economic Burden of Pleural Effusions (PE) In Patients with Chronic Myeloid Leukemia (CML).

Eric Qiong Wu, PhD, Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Denise Williams, MD, Amy Guo, PhD, Diego Ponce de Leon Barido, BA, BS, Andrew Peng Yu, PhD, Alfonso Quintás-Cardama, MD
Journal: Blood
Blood (2010) 116 (21): 3841.
https://doi.org/10.1182/blood.V116.21.3841.3841
Published: 2010
Journal Articles

Dose Adjustment and Treatment Interruptions Associated with Second-Line Nilotinib or Dasatinib In Real-World Treatment of Chronic Myeloid Leukemia

Andrew Peng Yu, PhD, Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Martin Cloutier, Bsc, Denise Williams, MD
Journal: Blood
Blood (2010) 116 (21): 4758.
https://doi.org/10.1182/blood.V116.21.4758.4758
Published: 2010